| Name | Title | Contact Details |
|---|
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
VitaPath Genetics is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharma Research International Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced Reproductive Care is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NutriSavings mission is to reduce the cost of healthcare by educating employees on healthy eating and rewarding good food choices with savings at the supermarket, grocery store, or farmers market. NutriSavings is a joint venture between Edenred (NYSE Euronext), the world leader in corporate services, and SavingStar, the only national fully digital grocery savings service in the US.